Fan, Jia

Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma

Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research

Inflammatory Biomarkers in Disease PrognosisHepatocellular Carcinoma Treatment and Prognosis

Cited by 2,493

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Ren, Z., Xu, J., Bai, Y., Xu, A., Cang, S., Du, C., Li, Q., Lu, Y., Chen, Y., Guo, Y., et al. (2021) · The Lancet Oncology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 1,124

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma

Gao, Q., Zhu, H., Dong, L., Shi, W., Chen, R., Song, Z., Huang, C., Li, J., Dong, X., Zhou, Y., et al. (2019) · Cell

Hepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus Studies

Cited by 1,096

Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection

Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory)

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 952

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R. (2016) · Cancer Research

Peptidase Inhibition and AnalysisImmune cells in cancer

Cited by 748

Metroticket 2.0 Model for Analysis of Competing Risks of Death after Liver Transplantation for Hepatocellular Carcinoma

Mazzaferro, V., Sposito, C., Zhou, J., Pinna, A. D., De Carlis, L., Fan, J., Cescon, M., Di Sandro, S., Yi-feng, H., Lauterio, A., et al. (2018) · Gastroenterology

Hepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and Outcomes

Cited by 655

Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer

Wu, D., Hu, D., Chen, H., Shi, G., Fetahu, I. S., Wu, F., Rabidou, K., Fang, R., Tan, L., Xu, S., et al. (2018) · Nature

Metabolism, Diabetes, and CancerEpigenetics and DNA Methylation

Cited by 477

Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study

Wang, Z., Ren, Z., Chen, Y., Hu, J., Yang, G., Yu, L., Yang, X., Huang, A., Zhang, X., Zhou, S., et al. (2018) · Clinical Cancer Research

Hepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus Studies

Cited by 318

Role of Extracellular Vesicles in Viral and Bacterial Infections: Pathogenesis, Diagnostics, and Therapeutics

Rodrigues, M., Fan, J., Lyon, C., Wan, M., & Hu, Y. (2018) · Theranostics

Extracellular vesicles in diseaseCellular transport and secretion

Cited by 191

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective

Xie, D., Shi, J., Zhou, J., Fan, J., & Gao, Q. (2023) · Clinical and Molecular Hepatology

Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies

Cited by 177

Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression

Song, G., Shi, Y., Zhang, M., Goswami, S., Afridi, S., Meng, L., Ma, J., Chen, Y., Lin, Y., Zhang, J., et al. (2020) · Cell Discovery

Immune cells in cancerCancer Immunotherapy and Biomarkers

Cited by 175

Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma

Chai, X., Wang, J., Li, H., Gao, C., Li, S., Wei, C., Huang, J., Tian, Y., Yuan, J., Lu, J., et al. (2023) · Gut Microbes

Cholangiocarcinoma and Gallbladder Cancer StudiesGut microbiota and health

Cited by 152

Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice

Zhao, W., Zhang, L., Yin, Z., Su, W., Ren, G., Zhou, C., You, J., Fan, J., & Wang, X. (2011) · International Journal of Cancer

Liver physiology and pathologyHepatocellular Carcinoma Treatment and Prognosis

Cited by 115

Distinct PD-L1/PD1 profiles and clinical implications in intrahepatic cholangiocarcinoma patients with different risk factors

Lu, J.-C., Zeng, H.-Y., Sun, Q.-M., Meng, Q.-N., Huang, X.-Y., Zhang, P.-F., Yang, X., Peng, R., Gao, C., Wei, C.-Y., et al. (2019) · Theranostics

Cholangiocarcinoma and Gallbladder Cancer StudiesCancer Immunotherapy and Biomarkers

Cited by 72

The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome

Xiang, Z.-L., Zeng, Z.-C., Fan, J., Tang, Z.-Y., He, J., Zeng, H.-Y., & Chang, J. Y. (2012) · Molecular Biology Reports

Hepatocellular Carcinoma Treatment and PrognosisCancer, Hypoxia, and Metabolism

Cited by 52